BONE BIOLOGICS CORP (BBLG) Stock News
NASDAQ:BBLG - Nasdaq - US0980705018 - Common Stock - Currency: USD
BBLG Latest News, Press Relases and Analysis
Get insights into the top gainers and losers of Friday's after-hours session.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Let's uncover which stocks are experiencing notable gaps during today's session.
Let's have a look at the gap up and gap down stocks in today's session.
Bone Biologics Announces Closing of $5.0 Million Public Offering
Why Is Bone Biologics Stock Surging On Friday?
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.
Bone Biologics Announces Pricing of $5.0 Million Public Offering
Stay updated with the stocks that are on the move in today's pre-market session.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Bone Biologics Files Patent Application for Bone Regeneration Technology
Get insights into the top gainers and losers of Thursday's after-hours session.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
Bone Biologics Announces 1-for-6 Reverse Stock Split
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
BBLG Stock Earnings: Bone Biologics Beats EPS for Q2 2024
BBLG stock results show that Bone Biologics beat analyst estimates for earnings per share the second quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns!
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com